// App-Quantinova.ai

TCT-57 : Impact of Lesion Length on 1-year Outcomes of Absorb Bioresorbable Vascular Scaffolds

Researchers

Presenter

  • Rony Lahoud

Principal Investigators

  • Stephen Ellis

  • Dean Kereiakes

  • Runlin Gao

  • Takeshi Kimura

  • Yoshinobu Onuma

  • Wai-Fung Cheong

  • Jennifer Jones

  • Zhengyang Zhang

  • Robert McGreevy

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Fords, New Jersey, United States

  • Kyoto University, Kyoto, Japan

  • The Christ Hospital, Cincinnati, Ohio, United States

  • Cancer Hospital CAMS&PUMC, Beijing, China

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

Locations

  • United States

  • China

  • Japan

  • Netherlands

Companies

  • Abbott

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved